Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial

Detalhes bibliográficos
Autor(a) principal: Müller,Eduardo Gayger
Data de Publicação: 2017
Outros Autores: Santos,Myrna Serapião dos, Freitas,Denise, Gomes,José Álvaro Pereira, Belfort Jr.,Rubens
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos brasileiros de oftalmologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300154
Resumo: ABSTRACT Purpose: To assess the efficacy of monotherapy using tacrolimus eye drops versus sodium cromoglycate for the treatment of vernal keratoconjunctivitis (VKC). Methods: Randomized double-masked controlled trial comparing the efficacy of tacrolimus 0.03% eye drops t.i.d. (Group 1) with sodium cromoglycate 4% eye drops t.i.d. (Group 2) for the symptomatic control of VKC at days 0, 15, 30, 45, and 90 of follow-up. Visual acuity, intraocular pressure, and other complications were evaluated to assess safety and side effects. Results: In total, 16 patients were included, with 8 enrolled in each group. Two patients from Group 2 were excluded from the analysis at days 45 and 90 because of corticosteroid use. Most patients were male (81.8%) and presented with limbal VKC (56.3%). There were statistically significant differences in favor of tacrolimus in the following severity scores: itching at day 90 (p=0.001); foreign body sensation at day 15 (p=0.042); photophobia at day 30 (p=0.041); keratitis at day 30 (p=0.048); and limbal activity at days 15 (p=0.011), 30 (p=0.007), and 45 (p=0.015). No relevant adverse effects were reported, except for a burning sensation with tacrolimus, though this did not compromise treatment compliance. Conclusion: Treatment with tacrolimus was superior to sodium cromoglycate when comparing severity scores for symptoms of itching, foreign body sensation, and photophobia, as well as for signs of limbal inflammatory activity and keratitis.
id CBO-2_4ce93da862b4188bb4d60ac8a38dc35c
oai_identifier_str oai:scielo:S0004-27492017000300154
network_acronym_str CBO-2
network_name_str Arquivos brasileiros de oftalmologia (Online)
repository_id_str
spelling Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trialConjunctivitisAllergicAnti-allergic agentsTacrolimusOphthalmic solutionsCromolyn sodiumABSTRACT Purpose: To assess the efficacy of monotherapy using tacrolimus eye drops versus sodium cromoglycate for the treatment of vernal keratoconjunctivitis (VKC). Methods: Randomized double-masked controlled trial comparing the efficacy of tacrolimus 0.03% eye drops t.i.d. (Group 1) with sodium cromoglycate 4% eye drops t.i.d. (Group 2) for the symptomatic control of VKC at days 0, 15, 30, 45, and 90 of follow-up. Visual acuity, intraocular pressure, and other complications were evaluated to assess safety and side effects. Results: In total, 16 patients were included, with 8 enrolled in each group. Two patients from Group 2 were excluded from the analysis at days 45 and 90 because of corticosteroid use. Most patients were male (81.8%) and presented with limbal VKC (56.3%). There were statistically significant differences in favor of tacrolimus in the following severity scores: itching at day 90 (p=0.001); foreign body sensation at day 15 (p=0.042); photophobia at day 30 (p=0.041); keratitis at day 30 (p=0.048); and limbal activity at days 15 (p=0.011), 30 (p=0.007), and 45 (p=0.015). No relevant adverse effects were reported, except for a burning sensation with tacrolimus, though this did not compromise treatment compliance. Conclusion: Treatment with tacrolimus was superior to sodium cromoglycate when comparing severity scores for symptoms of itching, foreign body sensation, and photophobia, as well as for signs of limbal inflammatory activity and keratitis.Conselho Brasileiro de Oftalmologia2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300154Arquivos Brasileiros de Oftalmologia v.80 n.3 2017reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.5935/0004-2749.20170038info:eu-repo/semantics/openAccessMüller,Eduardo GaygerSantos,Myrna Serapião dosFreitas,DeniseGomes,José Álvaro PereiraBelfort Jr.,Rubenseng2017-08-14T00:00:00Zoai:scielo:S0004-27492017000300154Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2017-08-14T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false
dc.title.none.fl_str_mv Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
title Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
spellingShingle Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
Müller,Eduardo Gayger
Conjunctivitis
Allergic
Anti-allergic agents
Tacrolimus
Ophthalmic solutions
Cromolyn sodium
title_short Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
title_full Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
title_fullStr Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
title_full_unstemmed Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
title_sort Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial
author Müller,Eduardo Gayger
author_facet Müller,Eduardo Gayger
Santos,Myrna Serapião dos
Freitas,Denise
Gomes,José Álvaro Pereira
Belfort Jr.,Rubens
author_role author
author2 Santos,Myrna Serapião dos
Freitas,Denise
Gomes,José Álvaro Pereira
Belfort Jr.,Rubens
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Müller,Eduardo Gayger
Santos,Myrna Serapião dos
Freitas,Denise
Gomes,José Álvaro Pereira
Belfort Jr.,Rubens
dc.subject.por.fl_str_mv Conjunctivitis
Allergic
Anti-allergic agents
Tacrolimus
Ophthalmic solutions
Cromolyn sodium
topic Conjunctivitis
Allergic
Anti-allergic agents
Tacrolimus
Ophthalmic solutions
Cromolyn sodium
description ABSTRACT Purpose: To assess the efficacy of monotherapy using tacrolimus eye drops versus sodium cromoglycate for the treatment of vernal keratoconjunctivitis (VKC). Methods: Randomized double-masked controlled trial comparing the efficacy of tacrolimus 0.03% eye drops t.i.d. (Group 1) with sodium cromoglycate 4% eye drops t.i.d. (Group 2) for the symptomatic control of VKC at days 0, 15, 30, 45, and 90 of follow-up. Visual acuity, intraocular pressure, and other complications were evaluated to assess safety and side effects. Results: In total, 16 patients were included, with 8 enrolled in each group. Two patients from Group 2 were excluded from the analysis at days 45 and 90 because of corticosteroid use. Most patients were male (81.8%) and presented with limbal VKC (56.3%). There were statistically significant differences in favor of tacrolimus in the following severity scores: itching at day 90 (p=0.001); foreign body sensation at day 15 (p=0.042); photophobia at day 30 (p=0.041); keratitis at day 30 (p=0.048); and limbal activity at days 15 (p=0.011), 30 (p=0.007), and 45 (p=0.015). No relevant adverse effects were reported, except for a burning sensation with tacrolimus, though this did not compromise treatment compliance. Conclusion: Treatment with tacrolimus was superior to sodium cromoglycate when comparing severity scores for symptoms of itching, foreign body sensation, and photophobia, as well as for signs of limbal inflammatory activity and keratitis.
publishDate 2017
dc.date.none.fl_str_mv 2017-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300154
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492017000300154
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/0004-2749.20170038
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
publisher.none.fl_str_mv Conselho Brasileiro de Oftalmologia
dc.source.none.fl_str_mv Arquivos Brasileiros de Oftalmologia v.80 n.3 2017
reponame:Arquivos brasileiros de oftalmologia (Online)
instname:Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
instname_str Conselho Brasileiro de Oftalmologia (CBO)
instacron_str CBO
institution CBO
reponame_str Arquivos brasileiros de oftalmologia (Online)
collection Arquivos brasileiros de oftalmologia (Online)
repository.name.fl_str_mv Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)
repository.mail.fl_str_mv aboonline@cbo.com.br||abo@cbo.com.br
_version_ 1754209029436997632